Browsing Clinical Studies by author "Cojocaru, Elena"
Now showing items 1-4 of 4
-
Adult soft tissue myoepithelial carcinoma: treatment outcomes and efficacy of chemotherapy.
Chamberlain, F; Cojocaru, E; Scaranti, M; Noujaim, J; Constantinou, A; et al. (OXFORD UNIV PRESS, 2019-12-27)Soft tissue myoepithelial carcinomas are a rare, malignant subgroup of myoepithelial tumours mostly arising in the extremities with equal predilection for women and men. The mainstay of management of localised disease is ... -
Multidisciplinary interventions in a specialist Drug Development Unit to improve family history documentation and onward referral of patients with advanced cancer to cancer genetics services.
Moss, CA; Cojocaru, E; Hanwell, J; Ward, S; Xu, W; et al. (ELSEVIER SCI LTD, 2019-06-01)BACKGROUND: Molecular aberrations in cancer may represent therapeutic targets, and, if arising from the germline, may impact further cancer risk management in patients and their blood relatives. Annually, 600-700 patients ... -
Real-world experience with doxorubicin and olaratumab in soft tissue sarcomas in England and Northern Ireland.
Gennatas, S; Chamberlain, F; Carter, T; Slater, S; Cojocaru, E; et al. (BMC, 2020-05-06)BACKGROUND: A randomised phase II trial demonstrated that the addition of olaratumab to doxorubicin significantly increased overall survival (OS) in patients with advanced soft tissue sarcomas (STS) compared to doxorubicin ... -
Telemedicine During the COVID-19 Pandemic: Impact on Care for Rare Cancers.
Smrke, A; Younger, E; Wilson, R; Husson, O; Farag, S; et al. (AMER SOC CLINICAL ONCOLOGY, 2020-06-01)PURPOSE: Many patients with cancer, often those with rare cancers such as sarcomas, travel long distances to access expert care. The COVID-19 pandemic necessitated widespread changes in delivery of cancer care, including ...